Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis - A Self-assessment Program
This self-assessment is the first activity in a larger curriculum (Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis). The activity utilizes a question-and-answer format to review key aspects in the evidence- and guidelines-based diagnosis and treatment of patients with psoriatic arthritis. Following completion of this activity, learners will be directed to in-depth, case-based activities that discuss further considerations in the management of psoriatic arthritis.
Medium: Mobile + Online
Commercial Support Statetements: This activity is supported by independent educational grants from AbbVie, Inc., and Celgene Corporation.
Joint Provider: MCM Education
Dermatologists, rheumatologists, primary care physicians, physician assistants (PAs), nurse practitioners (NPs), registered nurses (RNs) and other clinicians managing patients with psoriasis and/or psoriatic arthritis
After completing this activity, the participant will demonstrate the ability to:
- Diagnose PsA in patients with established psoriasis;
- Determine the severity of skin and joint symptoms in patients diagnosed with psoriasis and PsA;
- Assess the benefits and risks of available therapies for individual patients with mild to moderate psoriasis and PsA;
- Assess the benefits and risks of available therapies for individual patients with moderate to severe psoriasis and PsA.
Philip J. Mease, MD
Chief of Rheumatology Research
Swedish Medical Center
Clinical Professor of Medicine
University of Washington
Daniel Furst, MD
Carl Pearson Professor of Medicine
Department of Medicine, Division of Rheumatology
Director, Rheumatology Clinical Research Center
David Geffen School of Medicine at the University of California
Los Angeles, CA
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
Clinical Professor of Dermatology
University of Texas, Southwestern Medical School
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.